Have a personal or library account? Click to login
Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis Cover

Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis

Forum of Clinical Oncology
AHEAD OF PRINT
By: Lam Van Ngo,  Khanh Toan Nguyen,  Thi Huong Pham,  Uyen Tu Thi Nguyen,  Thanh Van Le,  Hien Thu Thi Tran,  Thi Thuy Phan and  Van Tuan Bui  
Open Access
|Sep 2025

References

  1. Waqar SN, Samson PP, Robinson CG, Bradley J, Devarakonda S, Du L, et al. Non-small cell lung cancer with brain metastasis at presentation. Clin Lung Cancer. 2018 Jul;19(4):e373–9.
    Search in Google ScholarBack to article
  2. Naresh G, Malik PS, Khurana S, Pushpam D, Sharma V, Yadav M, et al. Assessment of Brain Metastasis at Diagnosis in Non-Small-Cell Lung Cancer: A Prospective Observational Study From North India. JCO Glob Oncol. 2021 Apr;7:593–601.
    Search in Google ScholarBack to article
  3. An N, Jing W, Wang H, Li J, Liu Y, Yu J, et al. Risk factors for brain metastases in patients with non–small-cell lung cancer. Cancer Med. 2018 Nov 8;7(12):6357–64.
    Search in Google ScholarBack to article
  4. He J, Wang X, Xiao R, Zuo W, Zhang W, Yao H. Risk factors for brain metastases from non-small-cell lung cancer. Medicine (Baltimore). 2021 Mar 5;100(9):e24724.
    Search in Google ScholarBack to article
  5. Rice SR, Molitoris JK, Vyfhuis MAL, Edelman MJ, Burrows WM, Feliciano J, et al. Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at Diagnosis. Clin Lung Cancer. 2019 Jan;20(1):e107–14.
    Search in Google ScholarBack to article
  6. Ernani V, Stinchcombe TE. Management of Brain Metastases in Non–Small-Cell Lung Cancer. J Oncol Pract. 2019 Nov;15(11):563–70.
    Search in Google ScholarBack to article
  7. Descourt R, Greillier L, Perol M, Ricordel C, Auliac JB, Falchero L, et al. First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study). Cancer Immunol Immunother CII. 2023 Jan;72(1):91–9.
    Search in Google ScholarBack to article
  8. Wakuda K, Yabe M, Kodama H, Nishioka N, Miyawaki T, Miyawaki E, et al. Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression. Lung Cancer Amst Neth. 2021 Jan;151:60–8.
    Search in Google ScholarBack to article
  9. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, et al. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). JAMA Oncol. 2017 Jun 1;3(6):827–31.
    Search in Google ScholarBack to article
  10. Yoshida H, Kim YH, Iwatsubo S, Sakaguchi C, Sakamori Y, Nagai H, et al. Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan. Oncology. 2020;98(7):460–7.
    Search in Google ScholarBack to article
  11. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2015 Sep;10(9):1240–2.
    Search in Google ScholarBack to article
  12. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2016 Jan;11(1):39–51.
    Search in Google ScholarBack to article
  13. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649.
    Search in Google ScholarBack to article
  14. Lwanga SK, Lemeshow S, Organization WH. Sample size determination in health studies : a practical manual [Internet]. World Health Organization; 1991 [cited 2023 Jul 9]. Available from: https://apps.who.int/iris/handle/10665/40062
    Search in Google ScholarBack to article
  15. Zhu H, Zhou L, Guo Y, Yang G, Dong Q, Zhang Z, et al. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study. Future Oncol Lond Engl. 2021 Jul;17(19):2461–73.
    Search in Google ScholarBack to article
  16. Hao Y, Li G. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population-based cohort study. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. 2023 Sep 1;32(5):498–511.
    Search in Google ScholarBack to article
  17. Cacho-Díaz B, Cuapaténcatl LD, Rodríguez JA, Garcilazo-Reyes YJ, Reynoso-Noverón N, Arrieta O. Identification of a high-risk group for brain metastases in non-small cell lung cancer patients. J Neurooncol. 2021 Oct;155(1):101–6.
    Search in Google ScholarBack to article
  18. Iuchi T, Shingyoji M, Itakura M, Yokoi S, Moriya Y, Tamura H, et al. Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations. Int J Clin Oncol. 2015 Aug;20(4):674–9.
    Search in Google ScholarBack to article
  19. Remon J, Besse B. Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment. Front Oncol. 2018 Apr 11;8:88.
    Search in Google ScholarBack to article
  20. Berger A, Mullen R, Bernstein K, Alzate JD, Silverman JS, Sulman EP, et al. Extended Survival in Patients With Non-Small-Cell Lung Cancer-Associated Brain Metastases in the Modern Era. Neurosurgery. 2023 Jul 1;93(1):50–9.
    Search in Google ScholarBack to article
  21. Singh R, Lehrer EJ, Ko S, Peterson J, Lou Y, Porter AB, et al. Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020 Mar;144:165–79.
    Search in Google ScholarBack to article
  22. Balasubramanian SK, Sharma M, Venur VA, Schmitt P, Kotecha R, Chao ST, et al. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis. Neuro-Oncol. 2020 Feb 20;22(2):267–77.
    Search in Google ScholarBack to article
  23. Sperduto PW, De B, Li J, Carpenter D, Kirkpatrick J, Milligan M, et al. Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors. Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):60–74.
    Search in Google ScholarBack to article
  24. Churilla TM, Weiss SE. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer. Curr Oncol Rep. 2018 May 7;20(7):54.
    Search in Google ScholarBack to article
  25. Graber JJ, Cobbs CS, Olson JJ. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors. Neurosurgery. 2019 Mar 1;84(3):E168–70.
    Search in Google ScholarBack to article
  26. Gaspar LE, Prabhu RS, Hdeib A, McCracken DJ, Lasker GF, McDermott MW, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors. Neurosurgery. 2019 Mar 1;84(3):E159–62.
    Search in Google ScholarBack to article
  27. Thomas NJ, Myall NJ, Sun F, Patil T, Mushtaq R, Yu C, et al. Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2022 Jan;17(1):116–29.
    Search in Google ScholarBack to article
  28. Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet Lond Engl. 2016 Oct 22;388(10055):2004–14.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/fco-2024-0011 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Submitted on: Feb 7, 2025
|
Accepted on: Jun 16, 2025
|
Published on: Sep 12, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Brain metastases,
non-small cell lung cancer,
Vietnam
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2025 Lam Van Ngo, Khanh Toan Nguyen, Thi Huong Pham, Uyen Tu Thi Nguyen, Thanh Van Le, Hien Thu Thi Tran, Thi Thuy Phan, Van Tuan Bui, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT